UNSPSC 51161719: Prethcamide

This classification denotes a cns stimulant with the molecular formula C13H24N2O2.C12H22N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 41A1FCW148, chemically known as 2-butenamide, n-(1-((dimethylamino)carbonyl)propyl)-n-ethyl-, mixt. with n-(1-((dimethylamino)carbonyl)propyl)-n-propyl-2-butenamide but generally known as prethcamide, which bears US NIH Compound Identifier 71672. European Medicines Agency schedules Prethcamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB35623.

UNSPSC 51161719 Prethcamide is a Commodity code that in recent state and local procurement activity encompasses pharmaceutical products and pharmacy services, though the code's nominal scope and actual solicited work show minimal alignment. The two recent opportunities tagged to this code involve naloxone procurement and on-site pharmacy services delivery rather than prethcamide itself. Issuing bodies have included a Florida county health department (Seminole County) and a Georgia county government (Hall County), both seeking to support employee health plans and community health initiatives through competitive bidding or request-for-qualifications processes. Neither opportunity specifies set-aside restrictions based on disadvantaged-enterprise status.

Recent activity centers in Florida and Georgia. Seminole County, Florida issued an IFB on June 30, 2026 (response deadline July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building. Hall County, Georgia issued an RFQ/P on May 4, 2026 (response deadline June 4, 2026) for on-site pharmacy services at its Family Health Center Clinic in Gainesville to serve approximately 3,005 employees, retirees, and dependents across three health plan types; the county evaluated technical qualifications at 80% and cost at 20%, with contract start January 1, 2027. The code shows limited recent relevant activity — only two solicitations in the dataset, neither of which directly reflects the code's nominal pharmaceutical designation.